An insight into the role of telmisartan as PPAR‐γ/α dual activator in the management of nonalcoholic fatty liver disease-Reference-Cited by-同舟云学术

An insight into the role of telmisartan as PPAR‐γ/α dual activator in the management of nonalcoholic fatty liver disease

Published:2021-03 Issue: Volume: Page:
ISSN:0885-4513
Container-title:Biotechnology and Applied Biochemistry
language:en
Short-container-title:Biotechnology and Applied Biochemistry

Author:

Devan Aswathy R.¹^ORCID,Nair Bhagyalakshmi¹^ORCID,Kumar Ayana R.¹^ORCID,Nath Lekshmi R.¹^ORCID

Affiliation:

1. Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham AIMS Health Science Campus Kochi Kerala India

Funder

Amrita Vishwa Vidyapeetham University

Publisher

Wiley

Subject

Process Chemistry and Technology,Drug Discovery,Applied Microbiology and Biotechnology,Biomedical Engineering,Molecular Medicine,General Medicine,Bioengineering,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bab.2123

Reference74 articles.

1. Past, present and future perspectives in nonalcoholic fatty liver disease

2. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

3. Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future

4. Non-alcoholic fatty liver disease: a diabetologist’s perspective

5. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decreasing the burden of non-alcoholic fatty liver disease: From therapeutic targets to drug discovery opportunities;European Journal of Medicinal Chemistry;2024-11

2. Peptides Evaluated In Silico, In Vitro, and In Vivo as Therapeutic Tools for Obesity: A Systematic Review;International Journal of Molecular Sciences;2024-09-06

3. The role of peroxis proliferator-activated receptors in metabolic diseases;Medical alphabet;2024-09-05

4. The effects of antihypertensive drugs on glucose metabolism;Diabetes, Obesity and Metabolism;2024-08-14

5. Exploring the potential of drug repurposing for liver diseases: A comprehensive study;Life Sciences;2024-06